What Does Novocure Do?

Total employees1409
HeadquartersRoot D4
Founded2000

Novocure Inc. is a global oncology company dedicated to extending survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that disrupt cancer cell division. Novocure's primary product, Optune Gio® (formerly Optune®), is a non-invasive, portable medical device approved for the treatment of adult patients with glioblastoma (GBM) and in combination with chemotherapy for malignant pleural mesothelioma (MPM). The company is actively conducting clinical trials to evaluate the safety and efficacy of TTFields in various other solid tumor types, including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and brain metastases.

Where Is Novocure's Headquarters?

HQ Function

The Root, Switzerland office serves as Novocure's global headquarters, overseeing international operations, strategic planning, and corporate functions. It supports European commercial activities and global coordination.

Notable Features:

Modern office facilities designed to support a multinational biotechnology company, likely emphasizing collaborative workspaces and advanced communication technology.

Work Culture:

The work culture at Novocure's headquarters likely reflects a blend of Swiss precision and global ambition, focusing on innovation, scientific rigor, and a patient-centric approach to oncology.

HQ Significance:

The Swiss headquarters provides a central hub for Novocure's expanding European and global operations, access to a skilled international workforce, and a stable regulatory environment.

Values Reflected in HQ: The headquarters' operations likely reflect Novocure's core values of patient focus, innovation, integrity, and a drive to make a significant impact in cancer treatment.

Location:

Novocure operates globally with key functions distributed across North America, Europe, and Asia. This includes commercial operations in the U.S., Germany, Austria, Switzerland, Sweden, Japan, and Greater China; research and development primarily in Haifa, Israel, and supported by U.S. sites; global clinical trial management; and corporate functions headquartered in Switzerland. Their therapies are available in multiple countries, supported by regional offices and local teams focused on patient care, physician education, and market access.

Street Address:

Park 6

City:

Root D4

State/Province:

Lucerne

Country:

Switzerland

Where Else Does Novocure Operate Around the World?

Portsmouth, New Hampshire, USA

Address: 195 Commerce Way, Portsmouth, NH 03801, USA

Manages and expands Novocure's presence in the North American oncology market, ensuring patient access to TTFields therapy.

Malvern, Pennsylvania, USA

Address: 20 Valley Stream Parkway, Malvern, PA 19355, USA

Supports U.S.-based and global clinical development efforts, crucial for expanding TTFields indications.

Haifa, Israel

Address: Building 30, MATAM Advanced Technology Park, Haifa, 3190500, Israel

Drives the core scientific and technological advancements for Novocure's TTFields therapy platform.

Tokyo, Japan

Address: Marunouchi Kitaguchi Building 9F, 1-6-5 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan

Facilitates access to TTFields therapy for patients in Japan and expands Novocure's footprint in the Asian market.

St. Helier, Jersey

Address: No. 22 Grenville Street, St. Helier, Jersey JE4 8PX, Channel Islands

Fulfills legal and corporate domicile requirements.

Buying Intent Signals for Novocure

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Novocure? Meet the Executive Team

As of April 2025, Novocure' leadership includes:

William F. Doyle - Executive Chairman
Asaf Danziger - Chief Executive Officer
Ashley Cordova - Chief Financial Officer
Pritesh Shah - Chief Commercial Officer
Uri Weinberg - Chief Scientific Officer
Ely Benaim, M.D. - Chief Medical Officer
Frank X. Leonard - Special Advisor to the CEO (Former Chief Commercial Officer)
Moshe Levy - Chief Technology Innovation Officer
Willem G.C. Verweij - General Counsel

Who's Investing in Novocure?

Novocure has been backed by several prominent investors over the years, including:

Capital Research Global Investors
The Vanguard Group, Inc.
BlackRock, Inc.
Wellington Management Company LLP
Fidelity Management & Research Company LLC (FMR Co. LLC)
State Street Global Advisors (SSgA)

What Leadership Changes Has Novocure Seen Recently?

Hire1
Exits0

Novocure has experienced some key executive transitions over the past year, notably strengthening its commercial leadership.

New Appointments:

Pritesh Shah, Pritesh Shah appointed as new Chief Commercial Officer, bringing extensive experience in oncology commercialization.

What Technology (Tech Stack) Is Used byNovocure?

Discover the tools Novocure uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Novocure Email Formats and Examples

Novocure Inc. primarily uses the email format combining the first initial and last name of an employee, followed by '@novocure.com'. Variations might exist, but this is the most common pattern observed.

[firstinitial][lastname]@novocure.com

Format

jdoe@novocure.com

Example

85%

Success rate

What's the Latest News About Novocure?

Novocure Investor RelationsMay 2, 2024

Novocure Inc. news title: Novocure Reports First Quarter 2024 Financial Results and Provides Company Update

Novocure announced its financial results for the first quarter of 2024, reporting net revenues of $138.6 million and providing updates on its clinical trial programs, including progress in the LUNAR, PANOVA-3, and METIS studies....more

Novocure Investor RelationsApril 8, 2024

Novocure Inc. news title: Novocure to Present Nine Abstracts on Tumor Treating Fields Therapy at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Novocure announced it would present nine scientific abstracts highlighting research on Tumor Treating Fields (TTFields) therapy at the AACR Annual Meeting 2024, showcasing ongoing efforts to understand TTFields' mechanisms of action and explore new applications....more

GlobeNewswireMarch 19, 2024

Novocure Inc. news title: Novocure and Lapix Announce Exclusive License Agreement to Develop and Commercialize Novel Radiopharmaceuticals

Novocure and Lapix Therapeutics, Inc. entered into an exclusive license agreement for Lapix to develop and commercialize radiopharmaceutical products that utilize Novocure’s proprietary technology for targeted delivery to tumors. This marks Novocure's expansion into a new therapeutic modality....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Novocure, are just a search away.